Nanjing Well Pharmaceutical Group Co.,Ltd.
SSE:603351.SS
29.09 (CNY) • At close June 10, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 247.2 | 157.546 | 99.828 | 66.263 | 75.559 | 180.932 | 40.437 | 75.735 | 73.342 | 24.113 | 25.36 |
| Short Term Investments
| 83.413 | 1.252 | 1.106 | 26.238 | 196.711 | 90.314 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 247.2 | 158.798 | 100.934 | 92.501 | 272.269 | 271.246 | 40.437 | 75.735 | 73.342 | 24.113 | 25.36 |
| Net Receivables
| 242.789 | 251.019 | 191.184 | 203.984 | 97.177 | 166.303 | 152.726 | 132.142 | 104.776 | 101.121 | 83.599 |
| Inventory
| 202.025 | 170.577 | 165.129 | 142.442 | 115.045 | 114.888 | 100.881 | 94.395 | 64.334 | 63.308 | 61.061 |
| Other Current Assets
| 25.191 | 25.878 | 204.222 | 25.764 | 16.056 | 254.207 | 24.207 | 17.119 | 14.199 | 17.186 | 27.281 |
| Total Current Assets
| 717.205 | 599.421 | 470.285 | 464.691 | 500.548 | 823.299 | 318.252 | 319.391 | 256.651 | 205.728 | 187.641 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 1,448.955 | 1,498.988 | 1,481.663 | 1,211.713 | 940.803 | 500.654 | 369.319 | 305.301 | 234.801 | 181.592 | 154.646 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 111.91 | 98.372 | 93.529 | 77.481 | 78.491 | 80.142 | 42.483 | 42.408 | 43.139 | 44.071 | 44.614 |
| Goodwill and Intangible Assets
| 111.91 | 98.372 | 93.529 | 77.481 | 78.491 | 80.142 | 42.483 | 42.408 | 43.139 | 44.071 | 44.614 |
| Long Term Investments
| 0 | 70.04 | 67.688 | 13.762 | -156.711 | 4.183 | 0.665 | 1.185 | 1.393 | 0.559 | 0.618 |
| Tax Assets
| 6.902 | 9.25 | 5.981 | 11.692 | 1.423 | 1.261 | 1.751 | 2.56 | 2.242 | 1.17 | 0.9 |
| Other Non-Current Assets
| 95.942 | 2.83 | 19.015 | 62.087 | 271.862 | 48.732 | 75.728 | 54.676 | 62.009 | 54.384 | 30.88 |
| Total Non-Current Assets
| 1,663.709 | 1,679.482 | 1,667.875 | 1,376.735 | 1,135.868 | 634.971 | 489.947 | 406.13 | 343.583 | 281.776 | 231.659 |
| Total Assets
| 2,380.914 | 2,278.903 | 2,138.16 | 1,841.427 | 1,636.416 | 1,458.271 | 808.198 | 725.521 | 600.234 | 487.504 | 419.299 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 98.757 | 105.824 | 124.541 | 144.339 | 168.44 | 68.853 | 59.298 | 71.229 | 60.52 | 52.831 | 53.308 |
| Short Term Debt
| 376.199 | 382.894 | 362.004 | 171.193 | 104.857 | 102.217 | 94.761 | 85 | 62.207 | 115.207 | 107.5 |
| Tax Payables
| 8.363 | 13.323 | 24.845 | 1.168 | 7.576 | 5.185 | 4.711 | 1.32 | 6.014 | 3.19 | 2.3 |
| Deferred Revenue
| 0 | 0 | 9.092 | 89.946 | 33.327 | 22.733 | 4.711 | 15.979 | 17.669 | 18.84 | 16.378 |
| Other Current Liabilities
| 112.581 | 55.707 | 59.54 | 89.698 | 19.024 | 22.729 | 21.875 | 18.847 | 17.196 | 2.332 | 15.701 |
| Total Current Liabilities
| 595.901 | 557.748 | 580.021 | 422.696 | 307.629 | 198.984 | 180.645 | 176.396 | 145.937 | 192.4 | 178.809 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 47.322 | 104.064 | 56.384 | 13.598 | 11.413 | 0 | 0 | 0 | 0.121 | 0.328 | 0 |
| Deferred Revenue Non-Current
| 13.876 | 12.711 | 6.5 | 6.74 | 6 | 7.025 | 9.912 | 15.309 | 9.9 | -0.328 | 0 |
| Deferred Tax Liabilities Non-Current
| 15.617 | 11.699 | 12.851 | 12.979 | 11.712 | 11.046 | 3.031 | 1.021 | 0.288 | 0.284 | 0.136 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 76.815 | 128.474 | 75.735 | 33.317 | 29.125 | 18.071 | 12.943 | 16.329 | 10.309 | 0.612 | 0.136 |
| Total Liabilities
| 672.716 | 686.222 | 655.756 | 456.012 | 336.754 | 217.055 | 193.588 | 192.725 | 156.246 | 193.012 | 178.945 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 135.439 | 135.439 | 135.478 | 135.478 | 130.667 | 93.333 | 50 | 50 | 45.756 | 26.58 | 26.58 |
| Retained Earnings
| 555.699 | 456.67 | 382.514 | 330.905 | 280.092 | 231.949 | 156.895 | 86.646 | 272.062 | 252.806 | 198.134 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 2.789 | 75.652 | 29.675 | 46.716 | 36.412 | 23.358 | 396.15 | 125.797 | 14.769 | 0.516 |
| Other Total Stockholders Equity
| 1,010.786 | 989.525 | 962.3 | 916.322 | 842.188 | 915.933 | 407.715 | 396.15 | 125.797 | 0 | 14.769 |
| Total Shareholders Equity
| 1,701.924 | 1,584.423 | 1,480.292 | 1,382.706 | 1,299.662 | 1,241.215 | 614.61 | 532.796 | 443.615 | 294.154 | 239.999 |
| Total Equity
| 1,708.198 | 1,592.681 | 1,482.404 | 1,385.414 | 1,299.662 | 1,241.215 | 614.61 | 532.796 | 443.988 | 294.492 | 240.355 |
| Total Liabilities & Shareholders Equity
| 2,380.914 | 2,278.903 | 2,138.16 | 1,841.427 | 1,636.416 | 1,458.271 | 808.198 | 725.521 | 600.234 | 487.504 | 419.299 |